...
首页> 外文期刊>Carcinogenesis >The t10,c12 isomer of conjugated linoleic acid stimulates mammary tumorigenesis in transgenic mice over-expressing erbB2 in the mammary epithelium
【24h】

The t10,c12 isomer of conjugated linoleic acid stimulates mammary tumorigenesis in transgenic mice over-expressing erbB2 in the mammary epithelium

机译:共轭亚油酸的t10,c12异构体刺激在乳腺上皮中过度表达erbB2的转基因小鼠中的乳腺肿瘤发生

获取原文
获取原文并翻译 | 示例
           

摘要

Conjugated linoleic acid (CLA), a family of isomers of octadecadienoic acid, inhibits rat mammary carcinogenesis, angiogenesis, and lung metastasis from a transplantable mammary tumor. c9,t11-CLA, the predominant isomer in dairy products, and t10,c12-CLA, a component of CLA supplements, are equally effective. The objective of the current studies was to test the efficacy of these two CLA isomers in a clinically relevant breast cancer model. Transgenic mice over-expressing erbB2 in the mammary epithelium were fed control or 0.5% CLA-supplemented diets continuously from weaning. Unexpectedly, t10,c12-CLA stimulated lobular hyperplasia of the mammary epithelium and accelerated mammary tumor development, decreasing median tumor latency to 168 days of age compared with 256 and 270 days in the c9,t11-CLA and control groups, respectively. Metastasis was also increased by t10,c12-CLA, with percentage of tumor-bearing mice with lung metastasis 73, 14 and 31% in the t10,c12-CLA, c9,t11-CLA and control groups, respectively. A second study, in which CLA administration was initiated after puberty, confirmed the stimulatory effect of t10,c12-CLA on mammary tumor development and metastasis. Additionally, t10,c12-CLA, but not c9,t11-CLA, increased the size of the liver, heart, spleen and mammary lymph node. The effects of t10,c12-CLA were not specific to erbB2 transgenic mice, as t10,c12-CLA supplementation increased proliferation in the mammary epithelium of both wild-type FVB and FVB/erbB2 mice. Moreover, the number of terminal end buds, the mammary epithelial structures most sensitive to a carcinogenic insult, was increased 30-fold in FVB wild-type mice fed t10,c12-CLA. These data suggest that it would be prudent to avoid CLA supplements containing the t10,c12-CLA isomer. However, even though c9,t11-CLA was not efficacious in the erbB2 model, its ability to inhibit mammary tumor development in rat models suggests that it may have activity for prevention of some types of breast cancer.
机译:共轭亚油酸(十八碳二烯酸的异构体)共轭亚油酸(CLA)抑制大鼠乳腺癌发生,血管生成和可移植乳腺肿瘤的肺转移。 c9,t11-CLA(乳制品中的主要异构体)和t10,c12-CLA(CLA补充剂的成分)同等有效。当前研究的目的是在临床相关的乳腺癌模型中测试这两种CLA异构体的功效。从断奶开始,连续喂食对照或补充0.5%CLA的饮食,在乳腺上皮中过表达erbB2的转基因小鼠。出乎意料的是,t10,c12-CLA刺激了乳腺上皮的小叶增生并加速了乳腺肿瘤的发展,将中位肿瘤潜伏期降至168天,而c9,t11-CLA和对照组分别为256天和270天。 t10,c12-CLA也增加了转移,在t10,c12-CLA,c9,t11-CLA和对照组中,荷瘤小鼠的肺转移百分比分别为73%,14%和31%。青春期后开始进行CLA的第二项研究证实了t10,c12-CLA对乳腺肿瘤发生和转移的刺激作用。另外,t10,c12-CLA而不是c9,t11-CLA增加了肝脏,心脏,脾脏和乳腺淋巴结的大小。 t10,c12-CLA的作用对erbB2转基因小鼠不是特异的,因为补充t10,c12-CLA可以增加野生型FVB和FVB / erbB2小鼠在乳腺上皮中的增殖。此外,在接受t10,c12-CLA喂养的FVB野生型小鼠中,末端芽的数量(对致癌性损害最敏感的乳腺上皮结构)增加了30倍。这些数据表明,应避免使用含有t10,c12-CLA异构体的CLA补充剂。但是,即使c9,t11-CLA在erbB2模型中无效,但它在大鼠模型中抑制乳腺肿瘤发展的能力表明,它可能具有预防某些类型乳腺癌的活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号